Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions.

Saved in:
Bibliographic Details
Title: Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions.
Authors: Marshall AD; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia; Centre for Social Research in Health, University of New South Wales, Sydney, NSW, Australia. Electronic address: amarshall@kirby.unsw.edu.au., Willing AR; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia., Kairouz A; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia., Cunningham EB; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia., Wheeler A; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia., O'Brien N; Macquarie University, Sydney, NSW, Australia., Perera V; Macquarie University, Sydney, NSW, Australia., Ward JW; Coalition for Global Hepatitis Elimination, Task Force for Global Health, Decatur, GA, USA., Hiebert L; Coalition for Global Hepatitis Elimination, Task Force for Global Health, Decatur, GA, USA., Degenhardt L; National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia., Hajarizadeh B; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia., Colledge S; National Drug Research Institute, Curtin University, Perth, WA, Australia., Hickman M; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., Jawad D; Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Lazarus JV; Barcelona Institute for Global Health (IS Global), Hospital Clinic, University of Barcelona, Barcelona, Spain; CUNY Graduate School of Public Health and Health Policy, New York, NY, USA., Matthews GV; Therapeutic and Vaccine Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia; St Vincent's Hospital, Darlinghurst, Sydney, NSW, Australia., Scheibe A; TB HIV Care, Cape Town, South Africa; Community Orientated, Primary Care Research Unit, Department of Family Medicine, University of Pretoria, Pretoria, South Africa., Vickerman P; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., Dore GJ; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia., Grebely J; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia.
Corporate Authors: Global HCV and HIV Treatment Restrictions Group
Source: The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2024 Apr; Vol. 9 (4), pp. 366-382. Date of Electronic Publication: 2024 Feb 15.
Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101690683 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-1253 (Electronic) NLM ISO Abbreviation: Lancet Gastroenterol Hepatol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38367631
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Marshall+AD%22">Marshall AD</searchLink>; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia; Centre for Social Research in Health, University of New South Wales, Sydney, NSW, Australia. Electronic address: amarshall@kirby.unsw.edu.au.<br /><searchLink fieldCode="AU" term="%22Willing+AR%22">Willing AR</searchLink>; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Kairouz+A%22">Kairouz A</searchLink>; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Cunningham+EB%22">Cunningham EB</searchLink>; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Wheeler+A%22">Wheeler A</searchLink>; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22O'Brien+N%22">O'Brien N</searchLink>; Macquarie University, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Perera+V%22">Perera V</searchLink>; Macquarie University, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Ward+JW%22">Ward JW</searchLink>; Coalition for Global Hepatitis Elimination, Task Force for Global Health, Decatur, GA, USA.<br /><searchLink fieldCode="AU" term="%22Hiebert+L%22">Hiebert L</searchLink>; Coalition for Global Hepatitis Elimination, Task Force for Global Health, Decatur, GA, USA.<br /><searchLink fieldCode="AU" term="%22Degenhardt+L%22">Degenhardt L</searchLink>; National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Hajarizadeh+B%22">Hajarizadeh B</searchLink>; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Colledge+S%22">Colledge S</searchLink>; National Drug Research Institute, Curtin University, Perth, WA, Australia.<br /><searchLink fieldCode="AU" term="%22Hickman+M%22">Hickman M</searchLink>; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Jawad+D%22">Jawad D</searchLink>; Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Lazarus+JV%22">Lazarus JV</searchLink>; Barcelona Institute for Global Health (IS Global), Hospital Clinic, University of Barcelona, Barcelona, Spain; CUNY Graduate School of Public Health and Health Policy, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Matthews+GV%22">Matthews GV</searchLink>; Therapeutic and Vaccine Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia; St Vincent's Hospital, Darlinghurst, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Scheibe+A%22">Scheibe A</searchLink>; TB HIV Care, Cape Town, South Africa; Community Orientated, Primary Care Research Unit, Department of Family Medicine, University of Pretoria, Pretoria, South Africa.<br /><searchLink fieldCode="AU" term="%22Vickerman+P%22">Vickerman P</searchLink>; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Dore+GJ%22">Dore GJ</searchLink>; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Grebely+J%22">Grebely J</searchLink>; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Global+HCV+and+HIV+Treatment+Restrictions+Group%22">Global HCV and HIV Treatment Restrictions Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101690683%22">The lancet. Gastroenterology & hepatology</searchLink> [Lancet Gastroenterol Hepatol] 2024 Apr; Vol. 9 (4), pp. 366-382. <i>Date of Electronic Publication: </i>2024 Feb 15.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+B%2EV%22">Elsevier B.V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101690683 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2468-1253 (Electronic) <i>NLM ISO Abbreviation: </i>Lancet Gastroenterol Hepatol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38367631
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S2468-1253(23)00335-7
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 366
    Titles:
      – TitleFull: Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Marshall AD
      – PersonEntity:
          Name:
            NameFull: Willing AR
      – PersonEntity:
          Name:
            NameFull: Kairouz A
      – PersonEntity:
          Name:
            NameFull: Cunningham EB
      – PersonEntity:
          Name:
            NameFull: Wheeler A
      – PersonEntity:
          Name:
            NameFull: O'Brien N
      – PersonEntity:
          Name:
            NameFull: Perera V
      – PersonEntity:
          Name:
            NameFull: Ward JW
      – PersonEntity:
          Name:
            NameFull: Hiebert L
      – PersonEntity:
          Name:
            NameFull: Degenhardt L
      – PersonEntity:
          Name:
            NameFull: Hajarizadeh B
      – PersonEntity:
          Name:
            NameFull: Colledge S
      – PersonEntity:
          Name:
            NameFull: Hickman M
      – PersonEntity:
          Name:
            NameFull: Jawad D
      – PersonEntity:
          Name:
            NameFull: Lazarus JV
      – PersonEntity:
          Name:
            NameFull: Matthews GV
      – PersonEntity:
          Name:
            NameFull: Scheibe A
      – PersonEntity:
          Name:
            NameFull: Vickerman P
      – PersonEntity:
          Name:
            NameFull: Dore GJ
      – PersonEntity:
          Name:
            NameFull: Grebely J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2024 Apr
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2468-1253
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: The lancet. Gastroenterology & hepatology
              Type: main
ResultId 1